SUMMIT DETAILS
Earlier this year, we regrettably had to cancel the USA Summit in Washington and then the November Summit in London, due to Covid restrictions.
While it isn’t possible to welcome you in person, transitioning the Summit event online has given us the opportunity to create an event without geographical borders, combining the most compelling content on the science, evidence, policy and public health from an unparalleled line up of the leading scientists and researchers from across the globe.
We are delighted to publish the full agenda for The Virtual E-Cigarette Summit which will take place December 3-4. While we would ideally love for everyone to be able to join us for the live event, we appreciate that multiple time zones and challenging schedules means that joining the Summit for the duration in real time may be difficult, so we have designed the agenda to work as individual sessions which can be viewed on demand from December 1st. The Panel Debates and Q&A sessions will be live during their scheduled times (See Agenda) but you will have the opportunity to pose questions in advance and watch back later.
We hope that the Virtual Summit will provide a welcoming focal point to grapple with the challenging questions posed by e-cigarettes and new novel nicotine products. Although Covid, Brexit and the US Presidential Election dominate our news media, there is a considerable amount of change happening in the public health, policy and regulatory environments related to tobacco, e-cigarettes and harm reduction.
For decades, the known harms from smoking and combustible products has aligned public health and tobacco control colleagues behind a known “enemy”. The emergence of less harmful alternatives has resulted in a heated debate that continues to divide scientists, health professionals and policy makers alike. The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the latest research and exploring how the evidence should be interpreted, to deliver the most effective health strategies to reduce smoking related death and disease. We hope that you can join us.
SUMMIT CHAIRS 2020
Prof Ann McNeill
Professor of Tobacco Addiction,
Kings College London
Prof Ann McNeill, Professor of Tobacco Addiction & Vice Dean, Kings College London
Martin Dockrell
Tobacco Control Programme Lead,
Public Health England
Martin Dockrell, Tobacco Control Programme Lead, PHE
Prof Robert West
Emeritus Professor of Health Psychology, University College London
Prof Robert West, Emeritus Professor of Health Psychology, University College London
Prof Thomas Glynn
Stanford University School of Medicine
Prof Thomas J. Glynn
Adjunct Lecturer, Stanford University School of Medicine
CONFIRMED SUMMIT SPEAKERS 2020
Paul Lincoln OBE
Chair - Tobacco: preventing uptake, promoting quitting and treating tobacco dependence
(NICE) National Institute of Clinical and Health Excellence -
Dr Colin Mendelsohn MB BS (Hons)
General practitioner, Founding Chairman
Australian Tobacco Harm Reduction Association
Nicky Coote
Service Lead & Specialist Smoking Cessation Practitioner
Barnet Stop Smoking Service, Public Health
Dr Jasjit S. Ahluwalia
Physician and Professor
Brown University School of Public Health and Alpert Medical School
Louise Ross
Interim Chair and Mental Health Lead for the New Nicotine Alliance
Business Development Manager - Smoke Free - Quit Smoking Now
Prof Daniel Kotz
Professor in addiction research and clinical epidemiology, Institute of General Practice
Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Germany
Prof Linda Bauld, OBE
Bruce and John Usher Chair in Public Health in the Usher Institute
College of Medicine, University of Edinburgh
Prof Lion Shahab
Professor of Health Psychology
Department of Behavioural Science and Health, University College London
Dr Michael Pesko
Health Economist & Associate Professor
Department of Economics, Andrew Young School of Policy Studies, Georgia State University
Andrea Crossfield MBE
Independent Public Health Consultant and Population Health Policy Specialist
Greater Manchester Health and Social Care Partnership
Prof Alan Boobis, OBE
Emeritus Professor of Toxicology & Chair - UK Committee on Toxicity
Imperial College London
Prof Ann McNeill
Professor of Tobacco Addiction
Institute of Psychiatry, Psychology & Neuroscience,, Kings College London
Kate Pike
Co-ordinator - Trading Standards North West
Member of the Department of Health and Social Care National Tobacco Focus Group
Craig Copland
E-Cigarette Unit Manager - Vigilance and Risk Management of Medicines
MHRA - The Medicines and Healthcare products Regulatory Agency
Dr Debbie Robson RMN, PhD
Senior Lecturer in Tobacco Harm Reduction
National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London
Prof Tikki Pangestu
Visiting Professor, Yong Loo Lin School of Medicine
National University of Singapore
Richard Holley
Area Manager (Smoking Cessation), Tobacco Control Lead
Northamptonshire Stop Smoking Service
Rosanna O’Connor
Director, Addictions & Inclusion
Office for Health Improvement & Disparities, Department of Health and Social Care
Karl Fagerstrom
Professor Emeritus
President, Fagerstrom Consulting
Ray Niaura
Interim Chair of Dep't of Epidemiology, Professor of Social and Behavioural Sciences
School of Global Public Health, New York University
Professor Marcus Munafò
Professor of Biological Psychology and MRC Investigator
School of Psychological Science, University of Bristol
Prof Thomas J. Glynn, PhD
Adjunct Lecturer
Stanford Prevention Research Center, Stanford University School of Medicine
Prof Wayne Hall
Professor Emeritus, National Centre for Youth Substance Use Research
The University of Queensland
Prof Martin Jarvis
Emeritus Professor of Health Psychology, Department of Behavioural Science & Health
University College London
Prof Sanjay Agrawal
Professor of Respiratory Science, Institute of Lung Health
University Hospitals of Leicester NHS Trust, Chair of the Tobacco Special Advisory Group, Royal College of Physicians
Prof Robert Beaglehole
Emeritus Professor
University of Auckland, New Zealand & Chair ASH - Action for Smokefree 2025, NZ
Prof Steven A. Schroeder, MD
Distinguished Professor of Health and Healthcare
University of California, San Francisco & Director, Smoking Cessation Leadership Center
Prof Robin Mermelstein
Distinguished Professor of Psychology & Director, Institute for Health Research and Policy
University of Illinois, Chicago
Cliff Douglas JD
Director, Tobacco Research Network, Adjunct Professor, Dep't of Health Management and Policy
University of Michigan School of Public Health
Prof Kenneth Warner
Avedis Donabedian Distinguished University Professor Emeritus of Public Health and Dean Emeritus
University of Michigan School of Public Health
Prof Dorothy Hatsukami
Professor, Department of Psychiatry and Behavioral Sciences
University of Minnesota
Dr Jamie Hartmann-Boyce
Managing Editor, Cochrane Tobacco Addiction Group & Senior Research Fellow
University of Oxford
Dr Konstantinos Farsalinos M.D
External Research Associate
University of Patras, Department of Public and Community Health, University of West Attica, Greece
Prof Peter Hajek
Professor of Clinical Psychology
Wolfson Institute of Public Health, Queen Mary University of London
KEY THEMES TO BE EXPLORED
The Virtual E-Cigarette Summit 2020 will provide an inclusive platform to explore the latest research and scientific evidence. The Summit will run across 2 days and will be broken down into 7 separate sessions with a live Q&A opportunity with the panel, after each session:
Day 1 – Thursday 3 December
- Session 1: Science, Evidence and Research
- Session 2: Nicotine and Policy
- Session 3: THR and Public Health Policy
Day 2 – Friday 4 December
- Session 4: Tobacco Control, Industry and Regulation
- Session 5: Working with Tobacco Harm Reduction
- Session 6: Tobacco and Health Inequalities
- Session 7: Tobacco Control and THR
Keynote and closing address – Tobacco Control, Harm Reduction, and Science: Integrity is our most Important Asset
WHO SHOULD ATTEND
In particular, this event will be relevant to:
- Regulators and policy/government advisors
- Scientific/academic research community
- Clinical Commissioning Groups/PCT’s
- Smoking cessation practitioners/services
- Health charities and health campaigners
- Public health professionals
- Medical/health practitioners
- Industry and other stakeholders
The Summit independently provides hosted places for vapers and individuals without funding to attend. These places are discretionary and are considered on a case by case basis. If you would like to find out more please email info@smooth-events.com
WHO SHOULD ATTEND
- Regulators and policy/government advisors
- Scientific/research community
- Smoking cessation practitioners/services
- Health charities and health campaigners
- Public health professionals and academics
- Medical and health practitioners
- Industry and other stakeholders
The Summit independently provides hosted places for vapers and individuals without funding to attend. These places are discretionary and are considered on a case by case basis. If you would like to find out more please contact us by email on info@smooth-events.com
